Walgreens to pay Humana $360M to settle claims it overcharged for drugs

The latest stories trending on MedCity News.

Editor's Pick

Top Story Walgreens to Pay Humana $360M to Settle Claims It Overcharged for Drugs Walgreens has agreed to pay Humana $360 million to settle a drug pricing dispute that has spanned nearly five years. The payout is roughly half of what Walgreens was originally ordered to pay when the issue was first resolved last year. Sponsored Content The PBM Model of the Future: Why Payers Are Unbundling PBM Services Presented by MedCity News & Abarca Health Javier Gonzalez, Chief Growth and Commercial Officer at Abarca, about why payers are increasingly looking for alternatives to the traditional PBM model.  Learn More. Get Your Super Early Bird Pricing You still have time to secure your seat with our super early bird pricing ($995) on INVEST 2024. Connect with VCs, innovative startups, investors, and executives across healthcare for the best boutique networking event healthcare offers. Register Now

Featured News

MedCity News is Accepting Applications for the Healthcare Startup Pitch Perfect Contest in Chicago Each track will spotlight a different specialty area including: oncology, cardiology, women's health and preventing burnout/supporting operational efficiency. XRHealth Raises $6M for At-Home VR Therapy XRHealth's $6 million in funding was led by Asabys Partners and included participation from NOVA Prime Fund. The company will use the funding to support its recent merger with Amelia Virtual Care. At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy Though GSK divested much of its oncology assets to Novartis in 2015, the company has built back through a internal R&D and business development deals. GSK Senior Vice President, Global Head of Oncology, R&D Hesham Abdullah explained the company's evolving cancer strategy in an interview during the J.P. Morgan Healthcare Conference in San Francisco. Why One Healthcare Exec Is Optimistic About the ONC's New Info Sharing Rule Jill DeGraff, B.well Connected Health's senior vice president of regulatory, believes the ONC's new HTI-1 rule is a step in the right direction that will improve data exchange for providers, health tech vendors and patients. She applauded the rule for preserving TEFCA as a voluntary framework and for establishing FHIR-based interoperability as the industry's de facto standard. Unlocking Prior Authorization Access With a Green Lighting Approach The real-time, automated nature of green lighting offers precise control without the setbacks or manual efforts inherent to conventional gold carding programs. This innovative new approach also ensures adherence to state-level and other gold carding regulations Building Stronger Payer-Provider Alliances The healthcare industry stands to benefit greatly from stronger payer and provider partnerships. As the industry works to tear down the barriers that currently exist to bringing these stakeholders together, there are mutually beneficial opportunities that should be considered now.

Resources

How To Enable a Hyperpersonal Care Experience This on-demand webinar features expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients, barriers that hold health systems back, and will unpack Praia Health's technology capabilities. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe